DexCom Quarterly Balance Sheet

NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD

84.11-0.30 (-0.36%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

DexCom financial position

As of Jun 30, 2026, DexCom reported total assets of $6.46 billion, down 11.9% from a year earlier against total liabilities of $3.83 billion. Shareholders' equity stood at $2.62 billion, or 40.6% of assets. The company held $1.10 billion in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 1.73, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

DexCom balance sheet (quarterly)

DexCom quarterly balance sheet
Quarter (USD)	Q2 20262026-06-30	Q1 20262026-03-31	Q4 20252025-12-31	Q3 20252025-09-30	Q2 20252025-06-30	Q1 20252025-03-31	Q4 20242024-12-31	Q3 20242024-09-30	Q2 20242024-06-30	Q1 20242024-03-31	Q4 20232023-12-31	Q3 20232023-09-30
Cash & Equivalents	1.10B	1.12B	917.70M	1.84B	1.16B	904.90M	606.10M	621.20M	939.20M	851.20M	566.30M	643.70M
Short-Term Investments	—	—	—	—	—	1.56B	1.73B	1.65B	2.03B	1.77B	2.16B	2.60B
Receivables	1.26B	1.09B	1.22B	1.11B	1.35B	1.16B	1.01B	1.00B	945.20M	978.60M	973.90M	785.70M
Inventory	726.40M	693.60M	629.10M	604.10M	570.70M	538.20M	542.60M	586.30M	570.30M	589.10M	559.60M	498.60M
Total Current Assets	4.09B	4.33B	4.03B	5.22B	5.03B	4.55B	4.30B	4.26B	4.85B	4.62B	4.43B	4.70B
Property, Plant & Equipment	1.58B	1.56B	1.56B	1.47B	1.46B	1.36B	1.34B	1.32B	1.18B	1.11B	1.11B	1.08B
Goodwill	24.10M	24.20M	24.20M	24.10M	24.10M	23.10M	22.80M	23.80M	23.30M	23.20M	25.20M	25.30M
Intangible Assets	101.60M	62.60M	70.80M	79.00M	87.20M	95.20M	103.40M	106.20M	114.50M	123.30M	134.50M	144.50M
Long-Term Investments	209.50M	219.50M	218.00M	216.90M	115.80M	115.80M	119.30M	46.30M	43.60M	39.80M	38.50M	38.50M
Total Assets	6.46B	6.63B	6.34B	7.50B	7.33B	6.75B	6.48B	6.35B	6.80B	6.48B	6.26B	6.60B
Accounts Payable	423.80M	394.30M	344.30M	451.50M	472.00M	432.00M	345.30M	326.60M	307.00M	269.70M	276.40M	242.40M
Total Current Liabilities	2.36B	2.22B	2.14B	3.34B	3.31B	3.04B	2.93B	1.73B	1.72B	1.59B	1.56B	1.68B
Total Liabilities	3.83B	3.68B	3.59B	4.77B	4.75B	4.49B	4.38B	4.37B	4.36B	4.24B	4.20B	4.33B
Shareholders' Equity	2.62B	2.96B	2.75B	2.73B	2.57B	2.27B	2.10B	1.98B	2.43B	2.25B	2.07B	2.27B
Retained Earnings	2.88B	2.63B	2.43B	2.17B	1.88B	1.70B	1.60B	1.45B	1.31B	1.17B	1.02B	765.10M
Net Cash (Debt)	1.10B	1.12B	917.70M	1.84B	1.16B	2.46B	2.34B	2.27B	2.97B	2.62B	2.73B	3.24B
Shares Outstanding	377.40M	385.90M	384.80M	390.00M	392.20M	392.10M	390.70M	390.60M	400.70M	396.10M	385.40M	386.40M

This table shows 12 quarterly periods of DexCom's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow DXCM's reporting calendar. What is a balance sheet?